Intraoperative Fluid Administration and Surgical Outcomes Following Pancreaticoduodenectomy: External Validation at a Tertiary Referral Center.
Aged
Cohort Studies
Female
Fluid Therapy
/ adverse effects
Hospital Mortality
Humans
Intraoperative Care
/ adverse effects
Male
Middle Aged
Pancreatic Fistula
/ etiology
Pancreaticoduodenectomy
/ mortality
Postoperative Complications
/ etiology
Sepsis
/ etiology
Tertiary Care Centers
/ statistics & numerical data
Journal
World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
pubmed:
1
11
2018
medline:
27
6
2019
entrez:
1
11
2018
Statut:
ppublish
Résumé
While intraoperative fluid overload is associated with higher complication rates following surgery, data for pancreaticoduodenectomy are scarce and heterogeneous. We evaluated multiple prior definitions of restrictive and liberal fluid regimens and analyzed whether these affected surgical outcomes at our tertiary referral center. Studies evaluating different intraoperative fluid regimens on outcomes after pancreatic resections were retrieved. After application of all prior definitions of restrictive and liberal fluid regimens to our patient cohort, relative risks of each outcome were calculated using all reported infusion regimens. Five hundred and seven pancreaticoduodenectomies were included. Nine different fluid regimens were evaluated. Two regimens utilized absolute volume cutoffs, and the remaining evaluated various infusion rates, ranging from 5 to 15 mL/kg/h. Total volume administration of >5000 mL and >6000 mL was associated with increased complications (RR 1.25 and RR 1.17, respectively) and >6000 mL with increased sepsis (RR 2.14). Conversely, a rate of <5 mL/kg/h was associated with increased risk of postoperative pancreatic fistula (POPF, RR 3.16) and sepsis (RR 3.20), <6.8 mL/kg/h with increased major morbidity (RR 1.64) and sepsis (RR 2.27), and <8.2 mL/kg/h with increased POPF (RR 2.16). No effects were observed on pulmonary complications, surgical site infections, length of stay, or mortality. In an uncontrolled setting with no standard intraoperative or postoperative care map, the volume of intraoperative fluid administration appears to have limited impact on early postoperative outcomes following pancreaticoduodenectomy, with adverse outcomes only seen at extreme values.
Sections du résumé
BACKGROUND
BACKGROUND
While intraoperative fluid overload is associated with higher complication rates following surgery, data for pancreaticoduodenectomy are scarce and heterogeneous. We evaluated multiple prior definitions of restrictive and liberal fluid regimens and analyzed whether these affected surgical outcomes at our tertiary referral center.
METHODS
METHODS
Studies evaluating different intraoperative fluid regimens on outcomes after pancreatic resections were retrieved. After application of all prior definitions of restrictive and liberal fluid regimens to our patient cohort, relative risks of each outcome were calculated using all reported infusion regimens.
RESULTS
RESULTS
Five hundred and seven pancreaticoduodenectomies were included. Nine different fluid regimens were evaluated. Two regimens utilized absolute volume cutoffs, and the remaining evaluated various infusion rates, ranging from 5 to 15 mL/kg/h. Total volume administration of >5000 mL and >6000 mL was associated with increased complications (RR 1.25 and RR 1.17, respectively) and >6000 mL with increased sepsis (RR 2.14). Conversely, a rate of <5 mL/kg/h was associated with increased risk of postoperative pancreatic fistula (POPF, RR 3.16) and sepsis (RR 3.20), <6.8 mL/kg/h with increased major morbidity (RR 1.64) and sepsis (RR 2.27), and <8.2 mL/kg/h with increased POPF (RR 2.16). No effects were observed on pulmonary complications, surgical site infections, length of stay, or mortality.
CONCLUSIONS
CONCLUSIONS
In an uncontrolled setting with no standard intraoperative or postoperative care map, the volume of intraoperative fluid administration appears to have limited impact on early postoperative outcomes following pancreaticoduodenectomy, with adverse outcomes only seen at extreme values.
Identifiants
pubmed: 30377724
doi: 10.1007/s00268-018-4842-0
pii: 10.1007/s00268-018-4842-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
929-936Références
Lancet. 2002 May 25;359(9320):1812-8
pubmed: 12044376
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Am J Surg. 2005 Sep;190(3):393-400
pubmed: 16105525
Crit Care. 2005;9(6):R687-93
pubmed: 16356219
N Engl J Med. 2006 Jun 15;354(24):2564-75
pubmed: 16714767
Br J Anaesth. 2006 Dec;97(6):755-7
pubmed: 17098724
J Am Coll Surg. 2007 May;204(5):917-23; discussion 923-4
pubmed: 17481510
Anaesthesia. 2008 Jan;63(1):44-51
pubmed: 18086070
HPB (Oxford). 2007;9(1):8-15
pubmed: 18333107
Anesth Analg. 2009 Mar;108(3):887-97
pubmed: 19224798
Crit Care Med. 2010 Feb;38(2):464-70
pubmed: 19789444
Dis Colon Rectum. 2009 Dec;52(12):1935-40
pubmed: 19934912
Anaesth Intensive Care. 2010 Mar;38(2):259-65
pubmed: 20369757
Ann Surg. 2010 Dec;252(6):952-8
pubmed: 21107104
J Surg Oncol. 2012 Jan;105(1):81-4
pubmed: 21792977
Br J Anaesth. 2012 Aug;109(2):191-9
pubmed: 22710266
Clin Nutr. 2012 Dec;31(6):817-30
pubmed: 23079762
J Am Coll Surg. 2013 Jan;216(1):1-14
pubmed: 23122535
J Surg Oncol. 2013 Apr;107(5):529-35
pubmed: 23136127
Clin Res Hepatol Gastroenterol. 2013 Jun;37(3):230-9
pubmed: 23415988
J Crit Care. 2013 Aug;28(4):531.e7-15
pubmed: 23683558
Surgery. 2013 Sep;154(3):596-603
pubmed: 23876362
J Surg Oncol. 2013 Sep;108(4):242-7
pubmed: 23907788
J Invest Surg. 2014 Apr;27(2):88-94
pubmed: 24665844
BMC Anesthesiol. 2014 May 14;14:35
pubmed: 24839398
J Surg Oncol. 2014 Sep;110(4):407-11
pubmed: 24861716
Langenbecks Arch Surg. 2014 Oct;399(7):811-24
pubmed: 24962147
Ann Surg. 2014 Sep;260(3):445-53; discussion 453-5
pubmed: 25115420
Int J Surg. 2014 Dec;12(12):1467-72
pubmed: 25463768
J Am Coll Surg. 2015 Apr;220(4):530-6
pubmed: 25724606
Am J Surg. 2015 Nov;210(5):896-903
pubmed: 26255229
PLoS One. 2015 Oct 14;10(10):e0140294
pubmed: 26465290
Ann Surg. 2016 Oct;264(4):591-8
pubmed: 27355261
JAMA. 2016 Nov 15;316(19):2025-2035
pubmed: 27732721
Surgery. 2017 Mar;161(3):584-591
pubmed: 28040257
Pancreatology. 2017 May - Jun;17(3):334-341
pubmed: 28285959
Ann Med Surg (Lond). 2017 Feb 27;16:23-29
pubmed: 28289542
PLoS One. 2017 Sep 7;12(9):e0183313
pubmed: 28880931
World J Surg. 2018 Sep;42(9):2938-2950
pubmed: 29464346
N Engl J Med. 2018 Jun 14;378(24):2263-2274
pubmed: 29742967